NantKwest Announces Presentations At Upcoming Investment Conferences

CULVER CITY, Calif.--(BUSINESS WIRE)--NantKwest, Inc (NASDAQ:NK), a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases, today announced that the company will be presenting at two investment conferences in September: The Rodman & Renshaw 2016 Global Healthcare Conference and the Bank of America Global Healthcare Conference.

Back to news